The present study was undertaken to assess the cumulative effects of curcumin and quercetin in inhibiting the activity of COX-2 alongwith other biophysical parameters such as 3 H thymidine uptake as well as uptake and turnover of 14 C-glucose during BP induced lung carcinogenesis in mice. The mice were segregated into five groups viz., normal control, BP treated, BP + curcumin treated, BP + quercetin treated and BP + curcumin+ quercetin treated. Lung carcinogenesis was induced by a single intra-peritoneal (IP) injection of BP (100mg/Kg body weight). Curcumin and quercetin were supplemented to mice at dose levels of 60mg/Kg body weight and 40mg/Kg body wt in drinking water, respectively. All the treatments were continued for a period of 22 weeks. BP treatment brought about a significant increase in the activities of COX-2. Supplementation of phytochemicals individually as well in combination to BP treated mice brought about moderation in the enzymatic activity which was restored to within normal limits. Further, BP treatment recorded increased 3 H thymidine uptake as well as enhanced 14 C-glucose uptake and its turnover which were reduced significantly following simultaneous treatment with phytochemicals. Therefore, cumulative treatment with curcumin and quercetin has the potential of providing protection against lung cancer by inhibiting the COX-2 activity and moderating the 3 H thymidine uptake as well as 14 C-glucose uptake and its turnover.
Introduction
Lung cancer is one of the leading causes of cancer deaths in developed countries and is also rising at an alarming rate in developing countries [1, 2] when compared to other cancers such as breast, colorectal and prostate cancer put together. Lung cancers are virtually undetectable for most of the time as they grow from a single cell to a noticeable lesion.
Environmental pollutants and tobacco smoke insult to the lungs create a unique environment which leads to certain inflammatory signals in the lungs capable of affecting a variety of processes like apoptosis, angiogenesis, immune response, and tumor invasion [3] . There is every possibility of initiation and development of carcinogenesis with the participation from the lung inflammatory, structural, and stromal cells. The role of COX-2, which is responsible for release of proinflammatory prostaglandin PGE1, in lung carcinogenesis, has been under the scanner for sometime now. COX-2 has been shown to regulate some aspects of tumor-associated angiogenesis and its expression has been previously reported to be present in elevated levels as compared to normal lung tissue [4] [5] [6] . Certain chemopreventive agents have the capability to affect the COX-2 expression as one of their many functions thereby paving the way for cancer chemoprevention. There are certain agents which have the capability of inhibiting COX-2 and thus have the potential to impart antitumor effects against lung cancer. Phytochemicals such as curcumin and quercetin are such chemopreventive agents which have the potential to affect the COX-2 expression as well as its activity [7, 8] . Hence, the present study was undertaken to elucidate the effects of phytochemicals namely curcumin and quercetin on COX-2 activity alongwith other biophysical parameters including 3 H thymidine uptake as well as uptake and turnover 14 C-glucose during BP induced lung carcinogenesis.
Materials and methods

Chemicals
Benzo(a)pyrene (BP), curcumin and quercetin were procured from Sigma Aldrich company (St Louis, MO, USA). COX-2 colorimetric kit was from Cayman's chemicals USA. 3 H labelled thymidine and 14 C labelled Glucose were procured from Board of Radiation Isotope Technology (BRIT), Trombay, India.
Animals
Male laka mice in the weight range of 18-20 g were procured from the central animal house, Panjab University, Chandigarh, India. The animals were housed in polypropylene cages under hygienic conditions in the departmental animal house strictly in accordance with the guidelines as outlined by the institutional ethics committee.
Experimental design
Animals were segregated into five treatment groups. Animals in Group I served as normal controls and were administered with corn oil (I.P) intraperitoneally, which was used as a vehicle for the treatment of animals in BP group. Animals in Group II to V were given a single injection (IP) of BP at a dose level of 100mg/Kg body weight dissolved in corn oil [9] . Group III animals were given curcumin orally in water at a dose level of 60 mg /Kg/ b.wt thrice a week [10] . Animals in Group IV were given quercetin orally in water at a dose level of 40 mg/kg/b.wt in water thrice a week [11] [12] [13] . Both the phytochemicals were given to animals using intubation gavage technique. Animals in group V animals were given a combined treatment of curcumin and quercetin in a similar manner as was given to group III and group IV animals respectively. The treatment with phytochemicals to the animal belonging to groups III to V was started 10 days prior to BP injection. All the animals had free access to the diet and water and the treatments continued for a total duration of 22 weeks.
Body weight changes
A careful record of body weight changes of normal control, BP, curcumin, quercetin and curcumin + quercetin treated animals was kept throughout the study. The animals were weighed at the beginning of the experiment, then weekly and finally before sacrificing them. A daily record of food as well as water intake was also maintained throughout the study period.
Lung tumor incidence and tumor multiplicity analyses
After the terminal sacrifice following 22 weeks after BP treatment, lungs were removed from the mice, blotted dry and were examined for the visible macroscopic lesions. Tumors were easily discernable in the inflammated sections of the lung. The number of tumors was noted for tumor incidence and multiplicity studies
Lung weight changes
Following 22 weeks of BP treatment, the animals were sacrificed under ether anesthesia, lung excised and washed in normal saline. Lung weights were measured using Shimadzu Digital weighing balance.
Cox 2: Cox 2 enzyme activity was estimated by using Cayman's colorimetric assay kit.
Principle: Cayman's assay kit measures the peroxidase activity of Cox. It is assayed colorimetrically by monitoring the appearance of oxidized N, N, N', N'-tetramethyl-pphenylenediamine (TMPD) at 590 nm. The kit includes isozyme-specific inhibitors for distinguishing Cox 2 activity from Cox 1 activity.
Procedure
40 μL of each sample was added to the sample wells containing 120 μL of assay buffer and 10 μL of heme. Further, 40 μL of each sample was added to the inhibitor wells containing 110 μL of assay buffer ,10 μL of heme and 10 μL of specific inhibitor for Cox 2. The plate was shaken for a few seconds and was followed by incubation for 5 minutes at 25 0 C. Then, 20 μL of colorimetric substrate was added to each of the well and the reaction was initiated by the addition of 20 μL arachidonic acid to each well. The plate was shaken again for a few seconds and was subsequently incubated at 25 0 C for 5 minutes. The absorbance was read at 590 nm by using a plate reader. In-vitro uptake of 14 
C-D-Glucose :
The uptake of 14 C-D-Glucose was measured in the weighed lung slices by following the tissue accumulation method of Crane and Mendelstam [14] . 14 
Radiorespirometric determination of
Cglucose metabolism
Radiorespirometric method is the most sensitive method of analytical procedures. The application of this method to the in vitro measurement of metabolism can be accomplished by supplying 14 C-labeled substrates followed by collecting and measuring the radioactivity of the through respiration in the sample compartment was trapped on the wick and was measured directly in a liquid scintillation counter.
Statistical analysis
The statistical significance of the data has been determined using one-way analysis of variance (ANOVA) and a multiple post-hoc test of least significant difference (LSD). The results are represented as Mean ± S.D.
Results
Body weight changes
The deviation in the body weights of the animals subjected to different treatments from normal controls have been depicted in figure 1. The body weights of the normal control and treated mice increased progressively throughout the study. However, BP treatment resulted in a significant decrease in the body weights at the time interval twenty weeks when compared to the normal control mice. Supplementation with curcumin and quercetin individually as well as in combination improved the body weight growth in comparison to BP treated animals. Additionally, the daily food and water intakes were measured, and it was found that on an average 10-15 ml of water was consumed by each animal/day. However, no significant changes in food consumption were observed among various groups of animals.
A tumor incidence of about 89% was observed in the mice subjected to BP treatment ( Table 1) . When curcumin and quercetin were administered separately to BP treated mice, an appreciable decrease of about 12.5 % and 21.3 % respectively, in the tumor incidence was observed. Interestingly, combined treatment with these two phytochemicals was able to reduce the tumor incidence upto 32 %, signifying the advantage of combined treatment .The average number of tumors per tumor bearing mice (tumor multiplicity) was found to be 1.75 in BP treated mice. On the other hand, mice treated with curcumin, quercetin separately or in combination showed a decline in tumor multiplicity compared to mice administered with BP with levels of 1.42, 1.28 and 1.00, respectively. Figure 2 describes the lung weights of normal controls and mice subjected to various treatments. A significant increase in the lung weights was observed after 22 weeks of treatment duration when mice were subjected to single dose of BP treatment. Separate treatments with curcumin and quercetin for 22 weeks were able to decrease significantly the lung weights. Figure 3 depicts the enzymatic activity of cyclo-oxygenase 2 (COX-2), a proinflammatory enzyme in lungs of mice after 22 weeks of treatment schedule. BP treatment to mice brought about a statistically significant increase in the enzyme activity of COX-2 in the lungs of mice.
Lung weight changes
Supplementation with quercetin and curcumin alone to BP treated mice for 22 weeks did result in a significant decrease in the activity of the proinflammatory enzyme. Further, when both the phytochemicals were supplemented simultaneously to BP treated mice, the enzyme activity of COX-2 was restored to within normal limits. 
Radiorespirometric determination of 14 C glucose turnover
A statistically significant increase in the 14 C glucose turnover was noticed in the lungs of BP treated mice in the 22 weeks treatment schedule signifying increased glucose consumption of glucose due to faster cell proliferation (Figure 4) . When quercetin and curcumin was supplemented separately to BP treated mice, there was some decrease in the 14 C glucose turnover which was not statistically significant. However, curcumin + quercetin combined treatment resulted in a significant decrease in 14 C glucose turnover when compared with BP treated group. 14 C glucose A statistically significant increase in the 14 C glucose uptake was noticed in the lungs of BP treated mice (Figure 5) . When quercetin was supplemented alone as well as in combination with curcumin to BP treated mice, there was a significant decrease in the uptake values of 14 C glucose was observed. However, curcumin treatment alone also resulted in an appreciable decrease in the levels of 14 C glucose uptake in comparison to BP treated mice but the decrease was not statistically significant.
In vitro Uptake of
Uptake of 3 H-Thymidine:
A statistically significant increase (Figure 6 ) in the uptake of 3 H-thymidine was observed in the lungs of BP treated mice, signifying rapid DNA synthesis and proliferation of cells. However, supplementation with phytochemicals did cause a significant decrease in the 3 H-thymidine uptake values when given in combination and individual treatments with phytochemicals did produce some decrease in 3 H-thymidine incorporation the decrease it was not statistically significant
Discussion
The lungs are responsible for continuous uptake of oxygen and release of carbon dioxide and by doing so are exposed to toxins, pathogens and carcinogens present in the environment. There is every possibility that these inhaled agents might lead to oxidative injury and thus promote inflammatory responses [15] . This inflammatory response is responsible for combination of factors such as deregulated cell cycle, cytokines, and growth factors which can further lead to the development of lung cancer [16, 17] . The present study clearly demonstrates the potential of combined treatment of curcumin and quercetin in modulating pro-inflammatory enzyme COX-2 activity alongwith other biophysical parameters such as 3 H thymidine uptake as well as uptake and turnover of 14 C-glucose during BP induced lung carcinogenesis in mice.
The body weights of BP treated mice were observed to be decreased. This decrease in body weights might be due to cachexia in which the tumor induces metabolic changes in the host leading to loss of adipose tissue and skeletal muscle mass [18] . When curcumin and quercetin were administered to BP treated mice separately as well as in combination, a significant improvement in the body weights was observed. Curcumin has been reported to reduce muscle wasting by inhibiting multiple proteolytic pathways [19] . Quercetin alongwith other polyphenols, through its activation of SIRT1 has been reported to be beneficial in calorie restriction, metabolism and skeletal muscle function [20] .
Cyclo-oxygenase (COX) is a key enzyme responsible for conversion of arachidonic acid to prostaglandins (PGs) and other bioactive lipids, which in turn are involved in the regulation of normal growth responses and in aberrant cellular growth.COX has been demonstrated to exist in two distinct isoforms, COX-1 & COX-2 respectively [21] [22] [23] . COX-1 is expressed in most tissues and performs a housekeeping function [24] to synthesize PGs with normal cell regulatory activity, particularly in the gastrointestinal tract. Conversely, COX-2 is an inducible enzyme which is mostly silent but considerably up regulated by a wide array of stimuli such as interleukin (IL)-1, tumor necrosis factor α, platelet-derived growth factor, epidermal growth factor, lipopolysaccharide, and tumor promoters [25] . COX-2 has been shown to be implicated in the oncogenesis of many cancers [26] as constitutive expression of COX-2 is responsible for triggering the earliest steps of carcinogenesis. It has been reported that COX-2-deficient mice are more resistant to different forms of cancers [27] implicating its multi-step role in tumorigenesis, in early tumor promotion and in the late development of chemoresistance and metastatic formation [28] [29] [30] [31] . Preclinical studies do suggest that COX-2 may be involved in the molecular pathogenesis of some types of lung cancer. In lung cancer, COX-2 expression is observed at the majority stages of tumor progression. Clinical studies have demonstrated high levels of expression of COX-2 in almost all non small cell lung cancer preinvasive precursor lesions as well as invasive lung carcinomas, when compared to normal lung tissue [4] [5] [6] . Moreover, increased COX-2 expression is associated with a poor prognosis in lung cancer [32, 33] . Consistent with the preclinical studies, BP induced lung carcinogenesis in mice also showed an increase in the activity of COX-2 enzyme in the present study. This can further be linked with an observed increase in lung weights of BP treated mice. As inflammation is linked with cancer development and progression [34] [35] [36] , the resulting tumor incidence as well as multiplicity in the lungs of BP treated mice can be correlated with the high COX-2 activity. Supplementation of phytochemicals significantly reduced elevated activity of COX-2 and further normalized the lung weights as compared to normal controls. Curcumin exhibits its anti-inflammatory effect in part, through inhibition of the NF-kappaB pathway and cyclooxygenase 2 (COX-2) enzyme and thus plays a pivotal role in suppressing tumor cell growth [8, 37] . Goel and co-workers [38] showed that curcumin inhibits COX-2 expression in HT-29 cells, thereby affecting the growth of these human colon cancer cells. Quercetin's inhibition of COX and lipo-oxygenase (LOX) has been suggested as a means of its anti-inflammatory actions [7, 39] . Also, quercetin has been linked to its inhibition of pro-inflammatory metabolites of arachidonic acid [40] .
Radiorespirometric and uptake studies of 14 Cglucose showed a significant increase in the uptake and turnover of 14 C-glucose in lung slices of BP treated mice. Also, 3 H thymidine uptake was significantly increased in the lung slices of BP treated mice. The above mentioned increase in the 3 H-thymindine signifies increased DNA synthesis during rapid cell proliferation [41] [42] [43] , which might be due to high activity of COX-2 and would have resulted in the slowdown of apoptotic machinery in BP treated mice. Also, increase in cell proliferations requires high amount of glucose to survive [44] . So, the observed increase in 14 Cglucose uptake is a result of increase in requirement of glucose by rapidly proliferating cells following BP treatment. Combined treatment of curcumin and quercetin resulted in appreciable moderation in the uptake and turnover of glucose in the lungs of BP treated mice. The reason could be ascribed to the inhibition of COX-2 activity by phytochemical which induce apoptotic control over rapidly proliferating cells. The observation was confirmed by a decrease in the 3 H-thymidine uptake an indicator of cell proliferation following supplementation of phytochemicals to BP treated mice. The decrease in 14 C-glucose uptake and its turnover also gets substantiated when seen in context with decreased tumor incidence and multiplicity following combined supplementation of phytochemicals to BP treated mice.
Therefore, the study concludes that synergistic supplementation of curcumin and quercetin as a prophylactic therapy shall prove to be effective in containing hyperplasia by moderating COX-2 activity. 
